At the SCDM China Conference 2024, Patrick Nadoiny, SCDM Chair and Global Head of Clinical Data Management at Sanofi, delivered an insightful presentation. Sharon Chen, our CEO, showcased innovative Gen-AI applications.
Jun 27, 2024 Read More
At the DIA Global Annual Meeting, AlphaLife Sciences showcased advanced generative AI solutions, revolutionizing clinical trials with unmatched efficiency and speed, transforming drug development.
Jun 21, 2024 Read More
AlphaLife Sciences is grateful to join JLABS and the Global Roadshow at the BIO International Convention. This experience highlighted JLABS' support, fostering connections, and accelerating medical innovation through AI-based clinical research solutions.
Jun 10, 2024 Read More
AlphaLife Sciences joins Johnson & Johnson Innovation ‒ JLABS in Singapore, highlighting its promise in leveraging AI to accelerate clinical development and advance the medical AI field.
May 25, 2024 Read More
AlphaLife Sciences CEO Sharon Chen joined the Microsoft Build: AI Day in Bangkok, engaging with top CEOs and Satya Nadella on advancing AI and cloud technology.
May 02, 2024 Read More
Dear partners, we sincerely thank you for your collaboration with Alphalife Sciences throughout 2023. During this year, we engaged in comprehensive collaborations with many multinational pharmaceutical corporations (MNCs), leading domestic pharmaceutical companies, biotech firms, and mainstream CROs across various therapeutic areas, both domestically and internationally. These partnerships were instrumental in driving innovation in the pharmaceutical field and showcased the continual growth and advancement of Alphalife Sciences. Your ongoing support has been a driving force in our progress. Let's revisit this year filled with achievements.
Jan 09, 2024 Read More
In the surge of generativeAI, global pharmaceutical companies are actively exploring how to leverage AI to accelerate medical innovation and clinical trial processes. In this CMAC Clinical Research Informatization Club event at GSK industry colleagues will delve into 'The Latest Developments in Large Language Models in China' and 'Exploration of AI Applications in Pharmaceutical and Vaccine Development in China'.Ms. Sharon Chen, CEO of Alphalife Sciences and Chairperson of the CMAC Clinical Research Informatization Club, is invited as an honorary guest to share her profound insights on how generativeAI can assist enterprises in transforming clinical informatization. Additionally, Bogong Zhu, Chief Product Officer of Alphalife Sciences and a seasoned AI product expert, is also invited to participate in this event on AI and Pharmaceutical Innovation. Let's explore the endless possibilities of AI together and move towards a smarter and more efficient new era of clinical research!
Nov 23, 2023 Read More
The 2023 AI in Pharma Annual Conference will be held from Wednesday, October 4th, to Thursday, October 5th, 2023, in Boston. AI in Pharma is dedicated to providing a global platform for the exchange of ideas and collaboration to drive innovation in science and medicine. This two-day conference will explore specific applications and key challenges of artificial intelligence in drug discovery and clinical trials.
Sep 27, 2023 Read More
The 2023 SAPA Annual Meeting and 30th Anniversary Celebration will take place from September 29th (Friday) to 30th (Saturday) at the Hyatt Regency New Brunswick hotel in New Jersey. AlphaPrime Life Sciences is honored to sponsor this annual event. The theme of this year's meeting is "TOWARDS A SHARED VISION: ADVANCING PHARMACEUTICALS THROUGH COLLABORATION AND INNOVATION."
Sep 27, 2023 Read More
On September 5, 2023 — AlphaPrime Life Sciences Group (hereinafter referred to as "AlphaPrime"), announced its collaboration with Lunan Pharmaceutical Group Co., Ltd. (hereinafter referred to as "Lunan Pharmaceutical"), one of China's well-known comprehensive pharmaceutical companies, to officially launch the AuroraPrime Create (referred to as "Prime Create"), an intelligent clinical research document generation system. Lunan Pharmaceutical will fully utilize the system to write clinical research protocols and CSR (clinical study reports) to improve content writing, cross-team collaboration, and approval process efficiency, achieve digitization and structuring of document content, establish an enterprise-level content knowledge base, and realize comprehensive knowledge accumulation and application for innovative research and development.
Sep 05, 2023 Read More
